BRENT BURHITE: Open Payments
NPI 1851806327 · YORKTOWN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$458 in 30 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $72 · 2025 $458
Food & beverage: $458
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $165 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $68 |
| E.R. Squibb & Sons, L.L.C. | 2 | $52 |
| Janssen Pharmaceuticals, Inc | 3 | $51 |
| Axsome Therapeutics, Inc. | 3 | $45 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| TMS NeuroHealth Centers Inc. | 1 | $18 |
| Alkermes, Inc. | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, COBENFY, Auvelity, SPRAVATO, UZEDY, Jornay PM, TMS NeuroHealth Centers Inc..
Industry payments across VA — which companies pay providers there.
